Answers are grounded in this paper and cite their sources.
Background: Trousseau syndrome is a paraneoplastic hypercoagulable state manifesting as recurrent thromboembolism. Lung adenocarcinomas harboring specific driver mutations, such as ROS1 rearrangements, are associated with a significantly increased risk of these events and related complications. Case presentation: A 61-year-old non-smoking female with stage IV ROS1-positive lung adenocarcinoma developed bilateral cerebral and cerebellar infarctions. While aspirin therapy was initiated, she still experienced a recurrent ischemic stroke involving the left middle cerebral artery, leading to a diagnosis of Trousseau syndrome. However, the course was further complicated by pneumonia and respiratory failure. Anticoagulation with apixaban was initiated. A third embolic event subsequently occurred, involving a right middle cerebral artery occlusion with associated subarachnoid hemorrhage and hemorrhagic transformation. Despite intensive management, the patient’s condition deteriorated, and she passed away. Conclusions: Trousseau syndrome significantly impairs the prognosis of lung cancer patients, especially with specific driven genes, such as ROS-1 gene re-arrangement. This case highlights the deteriorating prognosis of cancer-associated thrombosis, which can be refractory and requires heightened clinical vigilance.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: